ID   NLF-TrkB, clone #6
AC   CVCL_UJ93
SY   NLF-TrkB, NTA#6
DR   Kerafast; ECP010
DR   Wikidata; Q98127940
RX   PubMed=26797418;
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Arg524Met (c.1571G>T); Zygosity=Heterozygous (from parent cell line).
CC   Transfected with: HGNC; 8032; NTRK2.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E217 ! NLF
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 6
//
RX   PubMed=26797418; DOI=10.1016/j.canlet.2016.01.018;
RA   Iyer R., Wehrmann L., Golden R.L., Naraparaju K., Croucher J.L.,
RA   MacFarland S.P., Guan P., Kolla V., Wei G., Cam N., Li G., Hornby Z.,
RA   Brodeur G.M.;
RT   "Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a
RT   xenograft mouse model.";
RL   Cancer Lett. 372:179-186(2016).
//